非コーディングRNA (ncRNA) が白血病幹細胞 (LSC) の機能に果たす役割:包括的なレビュー
Mehran Sharifi1, Shahram Nekoeian1, Reza Eshraghi2,3
1Department of Internal Medicine, School of Medicine, Cancer Prevention Research Center, Seyyed Al-Shohada Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.
Discover oncology
|August 25, 2025
まとめ
白血病幹細胞 (LSCs) は白血病の進行と治療抵抗を促します. このレビューでは,非コーディングRNA (ncRNA) が白血病の潜在的治療標的として,LSCおよび化学抵抗性におけるその役割を調査しています.
科学分野:
- 腫瘍学
- 分子生物学
- 癌 研究
背景:
- 癌の新規診断の2.5%と癌による死亡の3.1%が白血病によるものです
- 白血病幹細胞 (LSCs) は白血病の進行,免疫回避,および治療抵抗に不可欠です.
- 非コーディングRNA (ncRNA) は様々な細胞過程を調節し,様々な癌に関与しています.
研究 の 目的:
- 白血病における異常発現の ncRNAを調査する.
- 白血病の潜在的治療標的としてncRNAを調査する.
- LSCに化学抵抗性を与える ncRNAを検査する.
主な方法:
- 白血病におけるncRNAに関する研究の文献レビュー.
- 白血病におけるncRNA発現パターンの分析
- LSC機能と化学抵抗におけるncRNAメカニズムの研究
主要な成果:
- 長い非コーディングRNA,マイクロRNA,円形RNAを含むncRNAは,白血病では制御不能である.
- 特定のncRNAは,LSCの自己再生,分化,生存において重要な役割を果たします.
- ncRNAは白血病細胞に化学抵抗性を与えるのに関与しています.
結論:
- ncRNAは白血病の治療において有望な標的となる.
- ncRNAをターゲットにすることで,LSC媒介の化学抵抗を克服できる.
- 白血病のncRNA療法に関するさらなる研究が必要である.
関連する概念動画
lncRNA - Long Non-coding RNAs
8.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.9K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Lineage Commitment
3.1K
Commitment is the process whereby stem cells:
3.1K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K


